SciTransfer
Expertise area

High-containment pathogen research infrastructure

6 European H2020 organizations list this as part of their work1 as their primary capability.

Top organizations

Most active in this area

  • INSERM TRANSFERT SA

    Technology transfer arm of France's INSERM, managing IP and clinical translation across infectious disease, neurodegeneration, and precision medicine consortia.

    ERINHA2 and ERINHA-Advance focus on building European infrastructure for highly pathogenic agent research.

    FR33 projects
  • ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO

    Italy's national infectious disease hospital providing clinical validation for rapid diagnostics, vaccines, and therapeutics against high-consequence pathogens.

    Partner in EVAg and EVA-GLOBAL (European Virus Archive for reference virus collections), ERINHA2 and ERINHA-Advance (European infrastructure for highly pathogenic agents).

    IT21 projects
  • FOLKHALSOMYNDIGHETEN

    Sweden's national public health agency, specializing in infectious disease surveillance, rapid VHF diagnostics, and emerging pathogen vaccine development.

    Contributed to ERINHA2 and ERINHA-Advance, supporting Europe's BSL-4 research infrastructure for highly pathogenic agents.

    SE14 projects
  • INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE

    Portugal's national public health institute specializing in epidemiological surveillance, human biomonitoring, food safety, and health data infrastructure across European networks.

    Contributed to both ERINHA2 and ERINHA-Advance building European BSL-4 research infrastructure capacity.

    PT13 projects
  • INSTITUUT VOOR TROPISCHE GENEESKUNDE

    Belgium's leading tropical medicine institute, specializing in infectious disease research, epidemic emergency response, and health system strengthening across Africa, Asia, and Latin America.

    Participated in ERINHA2 for European high-pathogen research infrastructure and coordinated Ebola_Tx requiring BSL-4 level emergency trial capacity.

    BE13 projects
  • EUROPEAN RESEARCH INFRASTRUCTURE ON HIGHLY PATHOGENIC AGENTS

    European research infrastructure coordinating access to high-containment labs for studying dangerous pathogens, virus archiving, and outbreak response.

    ERINHA-Advance (which they coordinated), CORBEL, and EVA-GLOBAL all focus on life-science research infrastructure for dangerous biological agents.

    PrimaryBE6 projects